Abstract
Phantom limb pain (PLP) may occur in nearly 80% of amputation patients. Current research has highlighted several changes that occur in the nociception pathway post amputation. With this knowledge, novel therapies were found that could decrease PLP. Two such drugs are duloxetine and pregabalin, each effecting unique steps in the nociception pathway. We also review the neurobiology and efficacy of this treatment strategy.
Copyright 2010 Elsevier Inc. All rights reserved.
MeSH terms
-
Anticonvulsants / therapeutic use*
-
Drug Therapy, Combination
-
Duloxetine Hydrochloride
-
Female
-
Humans
-
Middle Aged
-
Nociceptors / physiology
-
Pain / diagnosis
-
Pain / drug therapy*
-
Pain / etiology*
-
Phantom Limb / complications*
-
Pregabalin
-
Selective Serotonin Reuptake Inhibitors / therapeutic use*
-
Thiophenes / therapeutic use*
-
gamma-Aminobutyric Acid / analogs & derivatives*
-
gamma-Aminobutyric Acid / therapeutic use
Substances
-
Anticonvulsants
-
Serotonin Uptake Inhibitors
-
Thiophenes
-
Pregabalin
-
gamma-Aminobutyric Acid
-
Duloxetine Hydrochloride